These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7332493

  • 21. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG, Gagarinova VM, Gorev NE, Shadrin AS.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [Abstract] [Full Text] [Related]

  • 22. Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition.
    Johansson BE, Kilbourne ED.
    Proc Natl Acad Sci U S A; 1994 Mar 15; 91(6):2358-61. PubMed ID: 8134399
    [Abstract] [Full Text] [Related]

  • 23. [Influenza virus neuraminidase and its role in anti-influenzal immunity].
    Isaeva EI, Platonova AL, Rovnova ZI, Kosiakov PN.
    Vopr Virusol; 1979 Mar 15; (6):615-9. PubMed ID: 524858
    [Abstract] [Full Text] [Related]

  • 24. Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations.
    Kendal AP, Bozeman FM, Ennis FA.
    Infect Immun; 1980 Sep 15; 29(3):966-71. PubMed ID: 7429641
    [Abstract] [Full Text] [Related]

  • 25. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination].
    Rudenko LG, Shvartsman IaS, Ispolatova AV, Grigor'eva EP, Drinevskiĭ VP.
    Vopr Virusol; 1989 Sep 15; 34(1):29-34. PubMed ID: 2728404
    [Abstract] [Full Text] [Related]

  • 26. Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.
    Jennings R, Clark A, Oxford JS, Hockley DJ, Potter CW.
    J Infect Dis; 1978 Nov 15; 138(5):577-86. PubMed ID: 712115
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A, Potter CW, Jennings R, Nicholl JP, Langrick AF, Schild GC, Wood JM, Tyrrell DA.
    J Hyg (Lond); 1983 Jun 15; 90(3):351-9. PubMed ID: 6863909
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies.
    Schotsaert M, Ysenbaert T, Smet A, Schepens B, Vanderschaeghe D, Stegalkina S, Vogel TU, Callewaert N, Fiers W, Saelens X.
    Sci Rep; 2016 Apr 13; 6():24402. PubMed ID: 27072615
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Antigenic structure of the neuraminidases of vaccinal strains of influenza virus type A used in the production of live anti-influenza oral vaccine].
    Mel'nikova SK, Aleksandrova AN, Alekseeva AK.
    Vopr Virusol; 1976 Apr 13; (3):287-9. PubMed ID: 62454
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M.
    J Infect Dis; 1999 May 13; 179(5):1132-8. PubMed ID: 10191214
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.